Our mission at Atlas Antibodies is to provide our customers with advanced research reagents targeting all human proteins.
You can choose between 21,000 primary antibodies for your research, validated for IHC, WB, ICC-IF. We're the original manufacturer of all our antibodies, Triple A Polyclonals and PrecisA Monoclonals. Triple A Polyclonals (Atlas Antibodies Advanced Polyclonals) are used to map the expression of all human proteins within the Human Protein Atlas project.
Producing highly characterized antibodies and working extensively with validation and reproducibility has always been of top priority. You can trust that our antibodies are specific and perform consistently each time you use them.
We welcome and take active part in the development of comprehensive guidelines for antibody validation as requested by the research community. We are setting the standard for antibody validation by further adding a layer of formal validation to our extensive product data, following the guidelines proposed by Uhlén et al in Nature Methods (September, 2016). Our strategy is to focus on four of the suggested pillars for antibody validation: Genetic Strategies, Orthogonal Strategies, Independent Antibody Strategies and Expression of Tagged Proteins.
In IHC we validate our antibodies by orthogonal methods by comparing the protein expression to RNA levels as well as comparing the result from independent antibodies directed towards different parts the same proteins.
At Atlas Antibodies, each new antibody lot is tested against its reference lot to make sure that new lots meet the same specificity critera in each application. This is how we guarantee lot-to- lot reproducibility.